AU3588795A
|
|
Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
|
US5766571A
|
|
Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids
|
US5536647A
|
|
Nucleic acids and vector encoding HMFQ polypeptide, transfected host, fusion proteins thereof, compositions thereof and methods of use thereof
|
US5972337A
|
|
46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
|
WO9411509A2
|
|
Peptides and anti-sense peptides with broad neoplastic specificity
|
WO9411508A2
|
|
Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
|
CA2148261A1
|
|
Anti-diarrheic product and method of treating rotavirus-associated infection
|
US5804187A
|
|
Modified antibodies with human milk fat globule specificity
|
US5532135A
|
|
Solid-phase competitive assay utilizing a fusion protein
|
US5792852A
|
|
Polynucleotides encoding modified antibodies with human milk fat globule specificity
|
US5455031A
|
|
Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
|